Orthogonal Nucleic Acid Oligomer Design for Assay Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Designing nucleic acid affinity pairs for multi-analyte tests poses challenges due to non-specific cross-interactions, especially with longer oligomers, which can lead to assay specificity issues and increased hybridization stability, making it difficult to prevent undesired hybridizations in applications like microarrays and nano-fabrications.
Innovation Solution
The development of a software program that generates orthogonal nucleic acid oligomer sequences, such as pRNA and pDNA, using a semi-random algorithm to ensure stability and avoid cross-reactivity, allowing for user-controlled variables to dictate the properties of the affinity pairs, including length and stringency of non-cross-interaction, and incorporating chimeric oligomers for improved binding characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If longer oligomers are used to increase binding stability, then hybridization stability is improved, but non-specific cross-interactions increase leading to decreased assay specificity
Solution Approach 1:
The patent uses a software program that systematically varies oligomer sequence parameters to identify combinations that achieve high binding stability while minimizing cross-interactions. The program evaluates multiple sequence parameters including GC content, melting temperature, and sequence composition to optimize the balance between stability and specificity
Solution Approach 2:
The patent employs computational modeling and in silico evaluation to create virtual representations of oligomer behavior before physical synthesis. The software program simulates hybridization stability and cross-interaction potential, allowing selection of optimal sequences without extensive experimental trial and error
2Adaptability or versatility
If more oligomer affinity pairs are designed for multi-analyte tests, then test coverage is improved, but cross-interaction between non-specific pairs increases
Solution Approach 1:
The patent designs a universal software program that can generate affinity pairs for multiple different analytes using the same methodology. The program evaluates sequences against a comprehensive database of potential cross-interactions, ensuring that pairs designed for different analytes maintain orthogonality and do not cross-react
Solution Approach 2:
The software program acts as an intermediary that mediates between the requirement for multiple affinity pairs and the need to avoid cross-interactions. It systematically evaluates potential pairs against each other, identifying and eliminating sequences that would cause non-specific binding before physical implementation
3Reliability
If short oligomers are used to avoid cross-interactions, then assay specificity is improved, but binding stability decreases
Solution Approach 1:
The patent systematically varies sequence parameters including GC content, melting temperature, and sequence composition to identify optimal short oligomer sequences that maximize binding stability while maintaining low cross-interaction potential. The software evaluates multiple parameter combinations to find the best balance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach effectively produces oligomer affinity pairs that minimize non-specific cross-interactions, enhancing the specificity of diagnostic assays and allowing for efficient site-specific immobilization of proteins and peptides on solid surfaces, thereby improving the accuracy of multi-analyte tests and lateral flow assays.
Implementation Method 1
one half of the pair is bound to the protein and the corresponding complementary oligomer is bound to the membrane
Implementation Method 2
Pyranosyl nucleic acid (pRNA), and 3-deoxypyranosyl nucleic acid (pDNA) are polymers that preferentially pair with complementary pRNA or pDNA versus natural RNA and DNA sequences
Data Source
AI summary
The invention provides methods to identify pRNA- and pDNA oligomer affinity pairs. Affinity pairs comprised of nucleic acid oligomers which demonstrate no cross-reactivity (“orthogonal”) are designed using software and empirically verified by thermodynamic study and lateral flow testing. The design software uses a semi-random algorithm to build such sequences of nucleic acid oligomers based on user-input parameters for affinity strength and orthogonal stringency. These pairs can be applied for use in multi-analyte solid support and lateral flow diagnostic tests.


